A Case of Poorly Differentiated Large-Cell Neuroendocrine Carcinoma of the Cecum: A Rare Malignancy, with Review of the Literature.

作者: Andrew T. Mertz , Michelle A. Ojemuyiwa

DOI: 10.1159/000452655

关键词: Poorly differentiatedNeuroendocrine CarcinomasCecumMedicineStage (cooking)ImmunotherapyLung cancerOncologyInternal medicineGastrointestinal tractMalignancy

摘要: Poorly differentiated neuroendocrine carcinomas (NECs) are rare tumors that can arise anywhere along the gastrointestinal tract. They often present in advanced stage and portend a poor prognosis when compared to adenocarcinomas of same stage. Characterization these is best accomplished with tissue biopsy, as peripheral tumor markers commonly used NECs little utility. Therapeutic strategies involve chemotherapeutic regimens have been treat small-cell lung cancer. Recent studies shown programmed death-ligand 1 (PD-L1) expression within poorly prognostic indicator. However, PD-L1 may represent possible target for immunotherapy drugs, called checkpoint inhibitors, such anti-PD-1 inhibitors.

参考文章(14)
Halfdan Sorbye, Jonathan Strosberg, Eric Baudin, David S. Klimstra, James C. Yao, Gastroenteropancreatic high-grade neuroendocrine carcinoma. Cancer. ,vol. 120, pp. 2814- 2823 ,(2014) , 10.1002/CNCR.28721
Jiabei He, Ying Hu, Mingming Hu, Baolan Li, None, Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung Cancer Scientific Reports. ,vol. 5, pp. 13110- 13110 ,(2015) , 10.1038/SREP13110
P. E. Bernick, D. S. Klimstra, J. Shia, B. Minsky, L. Saltz, W. Shi, H. Thaler, J. Guillem, P. Paty, A. M. Cohen, W. D. Wong, Neuroendocrine carcinomas of the colon and rectum. Diseases of The Colon & Rectum. ,vol. 47, pp. 163- 169 ,(2004) , 10.1007/S10350-003-0038-1
Hammad Shafqat, Shihab Ali, Mohammed Salhab, Adam J. Olszewski, Survival of Patients With Neuroendocrine Carcinoma of the Colon and Rectum Diseases of the Colon & Rectum. ,vol. 58, pp. 294- 303 ,(2015) , 10.1097/DCR.0000000000000298
Baruch Brenner, Laura H. Tang, David S. Klimstra, David P. Kelsen, Small-Cell Carcinomas of the Gastrointestinal Tract: A Review Journal of Clinical Oncology. ,vol. 22, pp. 2730- 2739 ,(2004) , 10.1200/JCO.2004.09.075
Staffan Welin, Halfdan Sorbye, Sigrunn Sebjornsen, Stian Knappskog, Christian Busch, Kjell Öberg, Clinical effect of temozolomide‐based chemotherapy in poorly differentiated endocrine carcinoma after progression on first‐line chemotherapy Cancer. ,vol. 117, pp. 4617- 4622 ,(2011) , 10.1002/CNCR.26124
Ariel Pedoeem, Inbar Azoulay-Alfaguter, Marianne Strazza, Gregg J. Silverman, Adam Mor, Programmed death-1 pathway in cancer and autoimmunity Clinical Immunology. ,vol. 153, pp. 145- 152 ,(2014) , 10.1016/J.CLIM.2014.04.010
B Brenner, MA Shah, M Gonen, DS Klimstra, J Shia, DP Kelsen, None, Small-cell carcinoma of the gastrointestinal tract: a retrospective study of 64 cases. British Journal of Cancer. ,vol. 90, pp. 1720- 1726 ,(2004) , 10.1038/SJ.BJC.6601758
Jonathan R Strosberg, Domenico Coppola, David S Klimstra, Alexandria T Phan, Matthew H Kulke, Gregory A Wiseman, Larry K Kvols, None, The NANETS Consensus Guidelines for the Diagnosis and Management of Poorly Differentiated (High-Grade) Extrapulmonary Neuroendocrine Carcinomas Pancreas. ,vol. 39, pp. 799- 800 ,(2010) , 10.1097/MPA.0B013E3181EBB56F
Anne M. Schultheis, Andreas H. Scheel, Luka Ozretić, Julie George, Roman K. Thomas, Thorsten Hagemann, Thomas Zander, Jürgen Wolf, Reinhard Buettner, PD-L1 expression in small cell neuroendocrine carcinomas. European Journal of Cancer. ,vol. 51, pp. 421- 426 ,(2015) , 10.1016/J.EJCA.2014.12.006